Patents by Inventor Marek G. Nelson

Marek G. Nelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibition of 26S and 20S proteasome by indanones
    Patent number: 6117887
    Abstract: This invention is novel indanone compositions useful for inhibiting cell proliferation disorders in mammals.
    Type: Grant
    Filed: June 2, 1998
    Date of Patent: September 12, 2000
    Assignee: CV Therapeutics, Inc.
    Inventors: Robert T. Lum, Steven R. Schow, Alison Joly, Suresh Kerwar, Marek G. Nelson, Michael M. Wick
  • Inhibition of 26S and 20S proteasome by indanones
    Patent number: 5834487
    Abstract: This invention is a method for inhibiting cell proliferation using indanones.
    Type: Grant
    Filed: September 24, 1996
    Date of Patent: November 10, 1998
    Assignee: CV Therapeutics
    Inventors: Robert T. Lum, Steven R. Schow, Alison Joly, Suresh Kerwar, Marek G. Nelson, Michael M. Wick
  • N.sup.6 mono heterocyclic substituted adenosine derivatives
    Patent number: 5789416
    Abstract: A substituted N.sup.6 -oxa, thia, thioxa and azacycloalkyl substituted adenosine derivative and a method for using the composition as an A.sub.1 heart adenosine receptor.
    Type: Grant
    Filed: August 27, 1996
    Date of Patent: August 4, 1998
    Assignee: CV Therapeutics
    Inventors: Robert T. Lum, Jurg R. Pfister, Steven R. Schow, Michael M. Wick, Marek G. Nelson, George F. Schreiner